openPR Logo
Press release

Mitral Valve Disease Market Insights Highlight Segment Expansion And Market Leadership

08-24-2026 04:06 PM CET | Health & Medicine

Press release from: The Business Research Company

Mitral Valve Disease Market

Mitral Valve Disease Market

The mitral valve disease market is poised for significant expansion as advancements in medical technology and treatment approaches continue to evolve. With rising adoption of innovative procedures and enhanced monitoring solutions, this sector is set to experience substantial growth in the years ahead. Let's explore the market size projections, leading players, current trends, and segment insights that define the future outlook of this important healthcare market.

Anticipated Growth of the Mitral Valve Disease Market by 2030
The market for mitral valve disease is projected to reach a value of $5.01 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This upward trajectory is largely fueled by the expansion of minimally invasive mitral valve procedures and a growing demand for transcatheter mitral valve replacement (TMVR) solutions. Additionally, increased adoption of remote cardiac monitoring systems, rising investments in valve repair devices, and the development of personalized therapies are key contributors to this growth. Important trends expected to influence the market during this period include breakthroughs in precision medicine-based treatments, the integration of artificial intelligence into mitral valve diagnostics and monitoring, growth in cloud-based cardiac imaging platforms, increased use of Internet of Things (IoT)-enabled remote monitoring devices, and the rise of robotic-assisted mitral valve repair technologies.

The mitral valve disease market size has grown strongly in recent years. It will grow from $3.28 billion in 2025 to $3.59 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of heart valve disorders, growing reliance on echocardiography diagnostics, rise in surgical mitral valve repair procedures, adoption of anticoagulation therapies, improved hospital cardiac care infrastructure.

Download a free sample of the mitral valve disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Driving the Mitral Valve Disease Market
Several well-established firms dominate the landscape of the mitral valve disease market, including Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical Technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., and Transcatheter Technologies GmbH.

Strategic Acquisition Enhances Market Position of Edwards Lifesciences
In July 2024, Edwards Lifesciences, a US-based leader in medical technology, completed the acquisition of Innovative Bio Medical Ltd., a UK-based company specializing in transcatheter mitral valve replacement (TMVR) technologies. Though financial details were not disclosed, this acquisition is expected to strengthen Edwards Lifesciences' portfolio in structural heart disease, addressing unmet clinical needs and supporting sustainable growth in the transcatheter mitral valve segment.

View the full mitral valve disease market report:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Shaping Mitral Valve Disease Treatments
Leading market players are focusing on developing stented tissue valves to meet the increasing demand for less invasive treatment alternatives. These valves are engineered to offer durability and reliable performance, providing patients with options beyond traditional surgical procedures. For example, in April 2024, Medtronic introduced the Avalus Ultra valve, a next-generation surgical aortic tissue valve. It aims to improve ease of implantation and long-term patient care by combining a low valve profile, a PEEK base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) that may enhance blood flow. The valve also features a radiopaque coil to facilitate better visualization during valve-in-valve interventions.

Detailed Segmentation and Forecast of the Mitral Valve Disease Market
This market is categorized into several segments for in-depth analysis:
1) Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, and Mitral Valve Therapeutics.
2) Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, and Mitral Valve Regurgitation.
3) End-User: Hospitals, Ambulatory Surgical Centers, and Other End-Users.

Further breakdown includes:
- Mitral Valve Repair subdivided into Surgical Repair, Minimally Invasive Repair, and Percutaneous Mitral Valve Repair.
- Mitral Valve Replacement divided into Mechanical Valve Replacement, Biological Valve Replacement, and Transcatheter Mitral Valve Replacement (TMVR).
- Mitral Valve Therapeutics encompassing Pharmacological Treatments, Anticoagulation Therapy, and Mitral Valve Repair Devices.

This segmentation provides a comprehensive view of the market's structure and aids in understanding the diverse treatment options and care settings involved in managing mitral valve disease.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mitral Valve Disease Market Insights Highlight Segment Expansion And Market Leadership here

News-ID: 4611624 • Views:

More Releases from The Business Research Company

Neurogenomics Market Report 2026 Market Outlook Supported By A Forecast 14.7% CA …
The neurogenomics market is on the brink of significant expansion, driven by technological advancements and increasing applications in clinical neurology. As research intensifies and precision medicine gains momentum, this market is set to experience notable growth and transformative trends that will shape its future trajectory. Projected Growth Trajectory of the Neurogenomics Market Forecasts indicate the neurogenomics market will reach a valuation of $2.98 billion by 2030, growing at a robust
Neurofibromatosis Treatment Market Insights Highlight Segment Expansion And Market Leadership
Neurofibromatosis Treatment Market Insights Highlight Segment Expansion And Mark …
The neurofibromatosis treatment market is poised for substantial expansion over the coming years, driven by advancements in precision medicine and therapeutic innovations. With rising awareness and improved diagnostic techniques, the demand for effective treatment options continues to accelerate. This overview explores the anticipated market size, emerging players, significant trends, and the key segments shaping the global neurofibromatosis treatment landscape by 2030. Forecasted Market Size and Growth Trajectory of the Neurofibromatosis Treatment
Neuroendocrine Tumor Treatment Market Report Evaluates Growth Drivers, Challenges And Market Dynamics
Neuroendocrine Tumor Treatment Market Report Evaluates Growth Drivers, Challenge …
The neuroendocrine tumor treatment market is on track for substantial growth in the coming years, driven by advancements in therapies and expanding healthcare infrastructure. This sector is witnessing innovation and increased adoption of cutting-edge treatment options that cater specifically to neuroendocrine tumors, positioning it for notable expansion by 2030. Forecasted Expansion and Market Value for Neuroendocrine Tumor Treatment The market for neuroendocrine tumor treatments is anticipated to grow rapidly, reaching
Molecular Modeling Market Research Reveals Path To $20.07 Billion By 2030
Molecular Modeling Market Research Reveals Path To $20.07 Billion By 2030
Exploring the future of molecular modeling reveals a promising trajectory marked by rapid expansion and technological innovation. As the demand for more efficient drug discovery and chemical analysis intensifies, the molecular modeling market is positioned to experience significant growth over the coming years. Let's delve into its projected market size, key players, emerging trends, and segmentation to understand this dynamic landscape better. Projected Growth and Size Outlook for the Molecular Modeling

All 5 Releases


More Releases for Valve

Selecting the Right Valve: Knife Gate Valve vs. Wedge Gate Valve
Choosing between a knife gate valve and a wedge gate valve isn't just about picking a piece of metal for your pipeline. It's about preventing costly downtime. Get it wrong, and you are looking at clogged lines, seat erosion, or total system failure. While both valves serve as isolation devices, they operate on completely different mechanical principles. At Tianjin Guoji Valve Co., Ltd. (widely recognized in the industry as TGV), we
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure. According to Fact.MR’s
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market